# Hydroxyprogesterone Caproate

NDC: 55150-311
Generic name: Hydroxyprogesterone Caproate
Labeler / Manufacturer: AuroMedics Pharma LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAMUSCULAR
Marketing started: 20190509

FDA application: ANDA211142

## Active ingredients

- HYDROXYPROGESTERONE CAPROATE: 1250 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55150-311"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55150-311
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=687bcf42-f437-42c7-8909-a91f621f55df